Depression and neurocognitive dysfunction in pediatric and young adult chronic kidney disease

Amy J Kogon1,2, Ji Young Kim3, Nina Laney4

  • 1Division of Nephrology, Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA, 19103, USA. kogona@email.chop.edu.

Insights

Depression is common in youth with chronic kidney disease (CKD). Obese CKD youth are more likely to be depressed, and depression impairs neurocognitive function in these patients.

Area of Science:

  • Pediatric Nephrology
  • Child and Adolescent Psychiatry
  • Neuropsychology

Background:

  • Depression affects a significant portion of children with chronic kidney disease (CKD), ranging from 7-35%.
  • In adults with CKD, depression is linked to adverse medical outcomes, social difficulties, and neurocognitive deficits.
  • The impact of depression on neurocognitive function in pediatric CKD populations remains poorly understood.

Purpose of the Study:

  • To identify factors associated with depression in youth diagnosed with CKD.
  • To investigate the effect of depression on neurocognitive performance in this demographic.
  • To explore potential therapeutic targets for improving outcomes in CKD youth.

Main Methods:

  • Cross-sectional study involving 71 CKD participants and 64 controls, aged 8-25 years.
  • Utilized depression inventories and comprehensive neurocognitive assessments.
  • Employed multivariable logistic and linear regression analyses to identify associations and effects, including an interaction term for CKD status and depression.

Main Results:

  • Obesity was significantly associated with depression in the CKD group (OR 10.25, P=0.01).
  • Depressed youth with CKD demonstrated significantly poorer performance (0.6-1.0 SD lower) in five neurocognitive domains: attention, visual memory, visual-spatial skills, visual working memory, and problem-solving.
  • These deficits were observed after adjusting for relevant clinical and demographic factors.

Conclusions:

  • Youth with CKD and obesity have a higher likelihood of experiencing depression.
  • Depression in youth with CKD is associated with impaired neurocognitive performance across multiple domains.
  • Targeting depression may be a viable strategy to enhance neurocognitive outcomes in pediatric CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
613
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
601
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
377
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
342
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K